ATE232390T1 - Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs - Google Patents

Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs

Info

Publication number
ATE232390T1
ATE232390T1 AT99916994T AT99916994T ATE232390T1 AT E232390 T1 ATE232390 T1 AT E232390T1 AT 99916994 T AT99916994 T AT 99916994T AT 99916994 T AT99916994 T AT 99916994T AT E232390 T1 ATE232390 T1 AT E232390T1
Authority
AT
Austria
Prior art keywords
fermented
laxant
prevention
treatment
colorectal cancer
Prior art date
Application number
AT99916994T
Other languages
English (en)
Inventor
Denis E Corpet
Sylviane Tache
Geraldine Parnaud
Original Assignee
Agronomique Inst Nat Rech
Envt Toulouse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9813450A external-priority patent/FR2784896B1/fr
Application filed by Agronomique Inst Nat Rech, Envt Toulouse filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of ATE232390T1 publication Critical patent/ATE232390T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99916994T 1998-10-27 1999-05-05 Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs ATE232390T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9813450A FR2784896B1 (fr) 1998-10-27 1998-10-27 Utilisation du polyethylene-glycol dans le traitement et la prevention des cancers colorectaux
FR9903240A FR2784897B1 (fr) 1998-10-27 1999-03-16 Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
PCT/FR1999/001065 WO2000024407A1 (fr) 1998-10-27 1999-05-05 Laxatif osmotique non fermente pour traiter et prevenir les cancers colorectaux

Publications (1)

Publication Number Publication Date
ATE232390T1 true ATE232390T1 (de) 2003-02-15

Family

ID=26234618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916994T ATE232390T1 (de) 1998-10-27 1999-05-05 Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs

Country Status (13)

Country Link
US (1) US6939563B2 (de)
EP (1) EP1124566B1 (de)
AT (1) ATE232390T1 (de)
AU (1) AU758348B2 (de)
BR (1) BR9914794A (de)
CA (1) CA2347170C (de)
DE (1) DE69905384T2 (de)
DK (1) DK1124566T3 (de)
ES (1) ES2192840T3 (de)
FR (1) FR2784897B1 (de)
NZ (1) NZ511150A (de)
PT (1) PT1124566E (de)
WO (1) WO2000024407A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002335900A1 (en) * 2001-10-29 2003-05-12 Shimizu Pharmaceutical Co., Ltd. Bowel cleansing agent
JP2007533755A (ja) * 2004-04-20 2007-11-22 ザ ユニヴァーシティ オヴ シカゴ 高分子量ｐｅｇ様化合物を含む治療薬送達システム
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
US9198847B2 (en) * 2004-11-05 2015-12-01 The Procter & Gamble Company Personal care composition containing a non-guar galactomannan polymer derivative and an anionic surfactant system
AU2013202513B2 (en) * 2005-05-06 2016-03-24 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
US7495063B2 (en) * 2006-02-03 2009-02-24 Dow Global Technologies Inc. Reduced oligomer concentration in high purity polyalkylene glycols
MX2008013576A (es) * 2006-04-24 2009-01-07 Bruce Medical Ab Agentes anticancerigenos a base de polimeros.
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
GB201018650D0 (en) * 2010-11-04 2010-12-22 Norgine Bv Methods and compositions
CA2947434A1 (en) 2014-04-29 2015-11-05 Colonaryconcepts Llc Foods, systems, methods, and kits for providing electrolyte replacement
WO2016140981A1 (en) 2015-03-02 2016-09-09 Colonaryconcepts Llc Compounds and methods for peg metabolite and peg breakdown product assays
US20220054534A1 (en) 2019-03-05 2022-02-24 Dow Global Technologies Llc Inducing caspase activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물

Also Published As

Publication number Publication date
AU758348B2 (en) 2003-03-20
DE69905384T2 (de) 2003-11-27
EP1124566B1 (de) 2003-02-12
FR2784897B1 (fr) 2002-11-29
WO2000024407A1 (fr) 2000-05-04
DK1124566T3 (da) 2003-06-02
US6939563B2 (en) 2005-09-06
AU3528399A (en) 2000-05-15
CA2347170A1 (fr) 2000-05-04
BR9914794A (pt) 2001-07-10
FR2784897A1 (fr) 2000-04-28
DE69905384D1 (de) 2003-03-20
PT1124566E (pt) 2003-06-30
EP1124566A1 (de) 2001-08-22
ES2192840T3 (es) 2003-10-16
NZ511150A (en) 2003-03-28
US20010051659A1 (en) 2001-12-13
CA2347170C (fr) 2011-09-20

Similar Documents

Publication Publication Date Title
NO20014662L (no) Fremgangsmåter og preparater for behandling av faste tumorer
PT1161248E (pt) Composição farmacêutica que contém uma fonte de nitrato e um agente acidificante destinada ao tratamento de feridas abertas e queimaduras
IL139231A0 (en) Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
DE69127175D1 (de) Antisens-Oligonukleotide zur Behandlung von Krebs
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
IS6647A (is) Kínasólínafleiður til að meðhöndla æxli
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
DE60032795D1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60118547D1 (de) Pharmazeutische zusammensetzung zur behandlung von kolorektalem krebs welche thalidomid und irinotecan enthält
MY164077A (en) Compositions and uses of et743 for treating cancer
TR200001147T2 (tr) Kanser ve makular dejenerasyonun tedavisi için makrolidlerin kullanımı
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ATE296635T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
ATE299025T1 (de) Pharmazeutische zubereitung enthaltend zytostatika und elektronenakzeptoren zur behandlung von krebs
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
EA200000568A3 (ru) Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы
DE69906532D1 (de) Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat
DE69720410D1 (de) Therapeutisches Mittel zur Behandlung hartnäckiger Hundedermatitis
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien
LT99030A (en) Drug plant composition for treatment of hemorrhoid and constipation
IT1304852B1 (it) Miscela di piante medicinali per la prevenzione e la cura delleemorroidi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1124566

Country of ref document: EP